Cipher Pharmaceuticals Inc.
CPH.TOTSXHealthcare● Active
$16.90
+$0.06(+0.36%)
Market Cap$429113342
P/E Ratio—
52W High$20.56
52W Low$11.98
Cipher Pharmaceuticals Inc. (CPH.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CPH.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $51.33M | $33.36M | $21.16M | $20.68M | $21.94M |
| Cost of Revenue | $17.56M | $9.26M | $4.07M | $3.99M | $3.68M |
| Gross Profit | $33.77M | $24.10M | $17.09M | $16.68M | $18.26M |
| Gross Margin %(computed) | 65.79% | 72.24% | 80.77% | 80.69% | 83.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.14M | $0.10M | $0.09M |
| G&A Expenses | $0.00M | $10.69M | $4.67M | $3.90M | $0.00M |
| Total Operating Expenses | $16.97M | $16.25M | $5.56M | $5.63M | $6.45M |
| Operating Income | $16.80M | $7.85M | $11.53M | $12.04M | $11.82M |
| Operating Margin %(computed) | 32.73% | 23.52% | 54.48% | 58.23% | 53.87% |
| Interest Income | $0.00M | $0.33M | $1.87M | $0.46M | $0.01M |
| Interest Expense | $1.19M | $0.00M | $0.00M | $0.00M | $0.09M |
| Income Before Tax | $17.46M | $2.96M | $12.68M | $11.48M | $11.06M |
| Income Tax Expense | ($10.34M) | ($8.59M) | ($7.70M) | ($15.16M) | $3.30M |
| Net Income | $27.81M | $11.54M | $20.38M | $26.64M | $7.76M |
| Net Margin %(computed) | 54.17% | 34.60% | 96.32% | 128.83% | 35.36% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.09 | $0.47 | $0.80 | $1.06 | $0.29 |
| Wtd Avg Shares | 25.48M | 24.72M | 25.48M | 25.13M | 26.60M |
| EBITDA | $16.80M | $11.87M | $11.53M | $12.04M | $13.66M |
| EBITDA Margin %(computed) | 32.73% | 35.56% | 54.48% | 58.23% | 62.25% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Cipher Pharmaceuticals Inc. data
About Cipher Pharmaceuticals Inc. (CPH.TO) Income Statement
Cipher Pharmaceuticals Inc. (CPH.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CPH.TO reported revenue of $0.05B, gross profit of $0.03B (gross margin 65.79%), and net income of $0.03B — a net profit margin of 54.17%.
Frequently asked questions
CPH.TO · 4 questionsCipher Pharmaceuticals Inc. (CPH.TO) reported revenue of $0.05B for 2025, up 53.9% year-over-year.
CPH.TO revenueCPH.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08